Valuation: Revvity, Inc.

Market Cap 12.69B 11.09B 10.2B 9.5B 18.03B 1,208B 18.3B 122B 47.58B 594B 47.64B 46.61B 2,047B P/E 2026 *
43.4x
P/E 2027 * 36x
Enterprise Value 14.31B 12.51B 11.49B 10.71B 20.32B 1,362B 20.63B 138B 53.64B 670B 53.7B 52.55B 2,307B EV / Sales 2026 *
5.05x
EV / Sales 2027 * 4.59x
Free-Float
99.65%
Yield 2026 *
0.25%
Yield 2027 * 0.24%
1 day-1.22%
1 week+1.32%
Current month+1.28%
1 month+12.34%
3 months+27.58%
6 months+7.26%
Current year+16.47%
1 week 109.62
Extreme 109.62
115.63
1 month 96.86
Extreme 96.855
116.16
Current year 81.22
Extreme 81.22
118.3
1 year 81.22
Extreme 81.22
118.3
3 years 79.5
Extreme 79.5
131.96
5 years 79.5
Extreme 79.5
203.16
10 years 45.35
Extreme 45.35
203.16
Manager TitleAgeSince
Chief Executive Officer 61 29/12/2019
Director of Finance/CFO 37 05/09/2022
Chief Tech/Sci/R&D Officer - 30/04/2023
Director TitleAgeSince
Chairman 68 29/12/2019
Director/Board Member 74 06/02/2012
Director/Board Member 72 26/07/2016
Date Insider Type Main position Quantity % Market Cap.
06-14Tax

Controller/Auditor

-33 0.0000%
05-06Free

Director

2,280 0.0020%
05-06Free

Director

2,280 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
-1.21%+1.32%+14.15%-2.76% 12.69B
-2.04%+1.41%+22.66%-0.72% 195B
+0.52%+5.51%-19.89%+29.75% 151B
-2.81%-0.03%-3.46%-17.78% 140B
-1.97%+2.02%-57.28%-16.11% 67.09B
+0.16%+3.73%+23.32%+4.55% 54.34B
-0.26%+2.41%-25.15%-29.38% 44.63B
-1.15%+2.02%+8.53%+42.01% 37.24B
-0.30%-1.71%+9.48%+10.24% 36.91B
+4.55%+9.57%-15.21%+1.13% 30.24B
Average -0.41%+2.49%-4.28%+2.09% 76.86B
Weighted average by Cap. -0.99%+3.39%-3.11%+2.15%

Financials

2026 *2027 *
Net sales 2.83B 2.48B 2.28B 2.12B 4.02B 270B 4.08B 27.31B 10.62B 133B 10.63B 10.4B 457B 2.98B 2.61B 2.39B 2.23B 4.23B 284B 4.3B 28.74B 11.17B 139B 11.19B 10.95B 481B
Net income 290M 254M 233M 217M 412M 27.61B 418M 2.8B 1.09B 13.57B 1.09B 1.07B 46.77B 346M 303M 278M 259M 492M 32.97B 499M 3.34B 1.3B 16.21B 1.3B 1.27B 55.85B
Net Debt 1.61B 1.41B 1.3B 1.21B 2.29B 154B 2.33B 15.57B 6.05B 75.58B 6.06B 5.93B 260B 973M 851M 782M 729M 1.38B 92.66B 1.4B 9.39B 3.65B 45.55B 3.65B 3.57B 157B
Logo Revvity, Inc.
Revvity, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows: - medical diagnosis equipment (50.1%); - analytical tools and instruments (49.9%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales break down by source of revenue between sales of products (83.7%) and services (16.3%). Net sales are distributed geographically as follows: America (44%), Europe (28.9%) and Asia (27.1%).
Employees
11,000
Date Price Change Volume
06/07/26 US$112.58 -1.04% 163,627
02/07/26 US$113.76 +0.82% 972,331
01/07/26 US$112.84 +1.42% 1,436,240
30/06/26 US$111.26 +0.04% 2,492,846
29/06/26 US$111.21 -1.60% 2,018,101
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
113.76USD
Average target price
113.73USD
Spread / Average Target
-0.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RVTY Stock